Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0307 |
Vernakalant
RSD1235,维那卡兰 |
Potassium Channel | Membrane transporter/Ion channel |
Vernakalant (RSD-1235) is a mixed ion channel blocker. | |||
T17227 |
Vernakalant Hydrochloride
RSD1235 hydrochloride |
Potassium Channel; Sodium Channel | Membrane transporter/Ion channel |
Vernakalant Hydrochloride (RSD1235 hydrochloride) 是一种混合电压和频率依赖性的 Na+ 和 K+ 通道阻断剂。Vernakalant 抑制 Kv1.5 channelwt,Kv1.5 channelI508F,Kv1.5 channelT479A,IC50 分别为 13.35±0.93 μM。 | |||
T39963 |
AP14145 hydrochloride
|
||
AP14145 hydrochloride is a potent negative allosteric modulator of K Ca 2 (SK) channels, specifically targeting K Ca 2.2 (SK2) and K Ca 2.3 (SK3) channels with an IC 50 of 1.1 μM. Inhibition of AP14145 hydrochloride is highly influenced by S508 and A533 amino acids present in the channel. This compound effectively extends the atrial effective refractory period (AERP) in rats and exhibits antiarrhythmic properties in a Vernakalant-resistant porcine model of atrial fibrillation (AF). | |||
T37821 | AP 14145 hydrochloride | ||
KCa2 (small conductance Ca2+-activated potassium) channel negative allosteric modulator (IC50 = 1.1 μM). Increases the EC50 of Ca2+ on KCa2.3 channels by ~3-fold. Prolongs atrial effective refractory period (AERP) in rats. Reduces atrial fibrillation (AF) duration and prolongs atrial refractoriness without affecting ventricular refractory period in an animal AF model. Diness et al (2017) Termination of vernakalant-resistant atrial fibrillation by inhibition of small-conductance Ca2+-activated K+... |